Study of gut bacteria in early COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial studies how gut bacteria (“gut flora”) may affect COVID-19 after a recent infection. If you test positive for COVID-19 soon enough, the study may help researchers understand why some people get better faster or have different symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be willing to sign consent and understand the study purpose and procedures
- Be 18 years or older
- Have a positive COVID-19 test (RT-PCR) within 1 week of the study screening
- You should not have had bariatric surgery or major bowel removal surgeries
- You should not have a stoma, ostomy, or ileoanal pouch, and should not be on IV nutrition (total parenteral nutrition)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at gut bacteria changes in people with and without long COVID symptoms after a confirmed COVID infection. It may help find why some people have long-term health problems.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This study looks at how bacteria and other microbes in your gut are linked to colorectal cancer risk and outcomes. By collecting stool samples from people newly diagnosed with colorectal cancer, researchers hope to find patterns that could improve understanding and future treatments.
This study looks at the bacteria in your gut (the microbiome) in people with chronic gut conditions. Researchers want to understand how gut bacteria differ in these conditions to help improve treatments.
This trial studies how your gut germs (microbiome) and gut lining change during a new bout of Campylobacter infection. It may help researchers understand what drives symptoms and how the gut recovers.
Hear when a new Gut Microbiome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.